Uni-Bio Science Group Limited (HKG:0690)

Uni-Bio Science Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	170.51	65.01	129.24	98.22	83.61	25.01
Short-Term Investments	24.07	118.89	12.36	10.4	6.72	15.62
Trading Asset Securities	-	-	-	-	-	36.03
Cash & Short-Term Investments	194.58	183.9	141.59	108.62	90.33	76.67
Cash Growth	8.95%	29.88%	30.35%	20.26%	17.82%	-19.00%
Accounts Receivable	100.43	70.24	53.22	57.87	71.63	74.77
Other Receivables	-	0.19	0.59	-	-	13.49
Receivables	129.51	101.1	60.11	57.87	71.63	88.26
Inventory	17.94	33.78	36.39	33.85	39.71	16.52
Total Current Assets	342.04	318.78	238.1	200.34	201.67	181.44
Property, Plant & Equipment	154.72	138.34	104.08	59.87	57.45	62.32
Long-Term Investments	0.41	-	-	-	-	-
Other Intangible Assets	2.08	2.24	2.67	3.09	3.81	4.1
Long-Term Deferred Tax Assets	4.13	4.12	3.85	0.43	-	-
Long-Term Deferred Charges	33.24	34.22	36.59	21.03	4.37	4.7
Other Long-Term Assets	19.43	19.44	15.47	7.71	0.3	0.17
Total Assets	556.05	517.55	409.99	292.47	267.59	252.72
Accounts Payable	15.88	15.23	9.31	5.27	5.26	3.83
Accrued Expenses	13.2	22.8	38.8	27.96	43.21	31.74
Short-Term Debt	6.07	5.26	8.86	0.13	-	-
Current Portion of Long-Term Debt	33	43.31	11.04	11.19	-	-
Current Portion of Leases	4.73	6.18	4.23	4.01	4.61	1.03
Current Income Taxes Payable	2.17	2.41	2.18	3.11	1.72	2.66
Current Unearned Revenue	16.62	17.67	25.16	21.81	20.21	13.18
Other Current Liabilities	8.95	10.64	15.22	16.78	17.29	7.93
Total Current Liabilities	100.61	123.5	114.79	90.26	92.3	60.37
Long-Term Debt	60.48	56.01	30.61	-	-	-
Long-Term Leases	9.79	9.7	6.99	7.47	0.99	2.11
Long-Term Unearned Revenue	0.15	0.26	-	-	-	-
Long-Term Deferred Tax Liabilities	2.17	2.45	0.43	-	-	0.83
Total Liabilities	173.2	191.91	152.82	97.73	93.29	63.31
Common Stock	59.71	59.71	63.65	63.65	63.5	63.91
Additional Paid-In Capital	709.15	725.69	751.76	751.76	750.77	754.89
Retained Earnings	-462.92	-544.52	-628.48	-699.36	-737.87	-718.28
Treasury Stock	-	-	-5.17	-	-	-
Comprehensive Income & Other	76.9	84.76	75.42	78.7	97.91	88.89
Shareholders' Equity	382.85	325.65	257.17	194.75	174.31	189.41
Total Liabilities & Equity	556.05	517.55	409.99	292.47	267.59	252.72
Total Debt	114.07	120.45	61.73	22.8	5.6	3.14
Net Cash (Debt)	80.52	63.45	79.87	85.82	84.73	73.53
Net Cash Growth	-7.03%	-20.55%	-6.94%	1.29%	15.23%	-21.39%
Net Cash Per Share	0.01	0.01	0.01	0.01	0.01	0.01
Filing Date Shares Outstanding	5,971	5,971	6,279	6,365	6,350	6,391
Total Common Shares Outstanding	5,971	5,971	6,279	6,365	6,350	6,391
Working Capital	241.43	195.28	123.31	110.09	109.36	121.07
Book Value Per Share	0.06	0.05	0.04	0.03	0.03	0.03
Tangible Book Value	380.77	323.41	254.51	191.66	170.5	185.31
Tangible Book Value Per Share	0.06	0.05	0.04	0.03	0.03	0.03
Buildings	-	86.67	87.95	88.88	90.45	88.85
Machinery	-	160.98	118.54	117.24	127.38	122.8
Construction In Progress	-	41.11	54.56	5.81	2.09	2.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.